We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$2.23B
AUM Growth
+$1.22B
(+121%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
60.06%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
1,418
New
876
Increased
102
Reduced
142
Closed
269
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$22.4M |
| 2 |
QuantumScape Corp
QS
|
+$15.9M |
| 3 |
MP Materials
MP
|
+$13.9M |
| 4 |
RP
RealPage, Inc.
RP
|
+$13.5M |
| 5 |
Green Plains
GPRE
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$25.6M |
| 2 |
AdaptHealth
AHCO
|
+$18.2M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$15.9M |
| 4 |
BHP
BHP
|
+$15.4M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.71% |
| 2 | Industrials | 5% |
| 3 | Consumer Discretionary | 4.69% |
| 4 | Technology | 4.51% |
| 5 | Financials | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Marvell Technology
MRVL
$174B
| – | – |
-7,344
| Closed | -$350K |
|
1252
Nautilus Biotechnolgy
NAUT
$215M
| – | – |
-100,000
| Closed | -$1.09M |
|
1253
New Jersey Resources
NJR
$6.06B
| – | – |
-8,911
| Closed | -$317K |
|
1254
NNN REIT
NNN
$9.39B
| – | – |
-5,000
| Closed | -$206K |
|
1255
CALL
NXP Semiconductors
NXPI
$68B
| – | – |
-1,300
| Closed | -$207K |
|
1256
Owens Corning
OC
$11.5B
| – | – |
-45,000
| Closed | -$3.46M |
|
1257
ONE Gas
OGS
$5.05B
| – | – |
-3,464
| Closed | -$266K |
|
1258
Oracle
ORCL
$331B
| – | – |
-4,785
| Closed | -$310K |
|
1259
Outfront Media
OUT
$5.64B
| – | – |
-113,472
| Closed | -$2.19M |
|
1260
Pacific Biosciences
PACB
$422M
| – | – |
-57,213
| Closed | -$1.51M |
|
1261
Parker-Hannifin
PH
$125B
| – | – |
-1,447
| Closed | -$418K |
|
1262
Phathom Pharmaceuticals
PHAT
$912M
| – | – |
-14,753
| Closed | -$497K |
|
1263
Pultegroup
PHM
$24.5B
| – | – |
-4,917
| Closed | -$217K |
|
1264
Personalis
PSNL
$1.26B
| – | – |
-35,658
| Closed | -$1.35M |
|
1265
Protagonist Therapeutics
PTGX
$8.75B
| – | – |
-90,000
| Closed | -$1.81M |
|
1266
PubMatic
PUBM
$581M
| – | – |
-33,050
| Closed | -$934K |
|
1267
Perella Weinberg Partners
PWP
$1.14B
| – | – |
-129,650
| Closed | -$1.48M |
|
1268
Replimune Group
REPL
$814M
| – | – |
-26,000
| Closed | -$1.1M |
|
1269
Repligen
RGEN
$7.44B
| – | – |
-25,000
| Closed | -$4.79M |
|
1270
RenaissanceRe
RNR
$13.7B
| – | – |
-10,059
| Closed | -$1.67M |
|
1271
Regal Rexnord
RRX
$14.2B
| – | – |
-1,979
| Closed | -$243K |
|
1272
Ryanair
RYAAY
$29.5B
| – | – |
-135,855
| Closed | -$6.09M |
|
|
SCHW
1273
Charles Schwab
SCHW
$177B
| – | – |
-5,870
| Closed | -$356K |
|
1274
Seer Inc
SEER
$108M
| – | – |
-5,713
| Closed | -$323K |
|
1275
Skillsoft
SKIL
$56.9M
| – | – |
-1,708
| Closed | -$355K |
|
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q1 2021 Portfolio in Review
As of Q1 2021, Maven Securities held 1,418 positions worth $2.23B, up 121% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Maven Securities deployed $1.34B of net new capital in Q1 2021, opening 876 new positions and adding to 102 existing holdings. Its largest new stake was QuantumScape Corp: 303,111 shares worth $13.5M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was AdaptHealth, an estimated $18.2M trimmed.
- Maven Securities's largest Q1 2021 buy was QuantumScape Corp: 303,111 shares worth $13.5M.
- Maven Securities added most to Invesco QQQ Trust in Q1 2021, an estimated $22.4M increase.
- Maven Securities's biggest Q1 2021 reduction was AdaptHealth, cutting an estimated $18.2M.
- Maven Securities fully exited Adaptive Biotechnologies in Q1 2021, selling an estimated $25.6M.
- Maven Securities's ten largest holdings make up 26% of its $2.23B portfolio in Q1 2021.
- Maven Securities opened 876 new positions and closed 269 in Q1 2021.
- Maven Securities's portfolio value rose 121% quarter-over-quarter to $2.23B.
Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.